4/A

PRIMARY DOCUMENT

Company: TENAX THERAPEUTICS, INC.
Filed: November 20, 2025
Period of Report: November 17, 2025
Accession Number: 0001492647-25-000004

View Document ↗ View on SEC.gov ↗